Technologies for molecular diagnostics are delivering new tools to the clinical community for faster and more accurate decision making. Learning what the demands of the community are, where the unmet medical need is, and how the assays can best perform, are critical questions to be asking. This meeting is the key conference for molecular diagnostics showcasing technologies and criteria for success such as market access and payment. It will encompass payers and reimbursement, emerging markets, comparative effectiveness, and benefits to clinical trial management and therapy selection for patients. In its ninth year, this meeting will present the dynamic factors shaping the industry, and the enormous growth opportunities that exist.
Conference Hound